DRL Impex Limited
About DRL Impex Limited
Data last updated:
DRL Impex Limited is a public limited company based in Hyderabad, Telangana, India, a subsidiary of Idea2enterprises India Private Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 18 August 1986 and has been in existence for over 40 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U65990TG1986PLC006695.
The company has an authorised share capital of ₹77 Cr and a paid-up capital of ₹76 Cr. It was formerly known as Drl Investments Limited and Drl Finance Ltd. It is led by directors including Mannam Venkata Narasimham and Namrata.
Its last annual general meeting (AGM) was held on 21 July 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 8 – 2 – 337 Road No. 3 Banjara Hills, Hyderabad, Telangana, India – 500034.
As per the financials filed for FY 2025, the company reported a revenue of ₹39.29 Lakh. For the same year it recorded a net loss of ₹15.06 Lakh (net margin -38.3%) and EBITDA of ₹38.69 Lakh (EBITDA margin 98.5%). Revenue has grown at a compounded annual rate (CAGR) of 159% over five years.
The company has 5 deals on record (4 secondary share transfers, 1 acquisition); the latest was in July 2018. Its 10 peer companies in the Chemicals industry (Formulations, Industrial Chemicals) are compared by revenue, 5 larger and 5 smaller; the largest is Marathwada Chemical Industries Private Limited with revenue of ₹39.54 Lakh.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address8 – 2 – 337 Road No. 3 Banjara Hills, Hyderabad, Telangana, India – 500034
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of DRL Impex Limited FY 2025 filings available
DRL Impex Limited reported revenue of ₹39.29 Lakh for FY 2025.
Compounded Annual Growth Rate (CAGR) of DRL Impex Limited
Revenue has grown at a compounded annual rate (CAGR) of 159% over five years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of DRL Impex Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹38.69 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹15.06 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of DRL Impex Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 98.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -38.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of DRL Impex are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of DRL Impex Limited
DRL Impex Limited is compared with the companies closest to it by revenue in the Chemicals industry (Formulations, Industrial Chemicals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Marathwada Chemical Industries Private Limited | ₹39.54 Lakh (FY 2025) | •••• | •••• | -96.0% | •••• | Aurangabad, Maharashtra, India |
| MKM Formulations Private Limited | ₹39.51 Lakh (FY 2025) | •••• | •••• | -32.0% | •••• | Pune, Maharashtra, India |
| Asap Pharmaceuticals Private Limited | ₹39.48 Lakh (FY 2025) | •••• | •••• | 5.0% | •••• | Patna, Bihar, India |
| VMP Health Care India Private Limited | ₹39.47 Lakh (FY 2025) | •••• | •••• | 13.0% | •••• | Thane, Maharashtra, India |
| Dr. Alson Laboratories Private Limited | ₹39.35 Lakh (FY 2025) | •••• | •••• | -18.0% | •••• | Delhi, India |
| DRL Impex Limited this company | ₹39.29 Lakh (FY 2025) | •••• | •••• | •••• | Hyderabad, Telangana, India | |
| Salsim Pharma Private Limited | ₹39.21 Lakh (FY 2025) | •••• | •••• | 50.0% | •••• | New Delhi, Delhi, India |
| Cureclip Pharmaceuticals Limited | ₹39.18 Lakh (FY 2025) | •••• | •••• | -94.0% | •••• | Delhi, India |
| Unilink Bioscientific Remedies Private Limited | ₹39.16 Lakh (FY 2024) | •••• | •••• | -22.0% | •••• | Pune, Maharashtra, India |
| Rhisystre India Private Limited | ₹39.13 Lakh (FY 2025) | •••• | •••• | -14.0% | •••• | Siliguri, West Bengal, India |
| Modern Industrial Chemicals Pvt Ltd | ₹39.12 Lakh (FY 2025) | •••• | •••• | -30.0% | •••• | Kolkata, West Bengal, India |
Peers are the five companies nearest above and the five nearest below DRL Impex by revenue in the Chemicals industry (Formulations, Industrial Chemicals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of DRL Impex Limited
DRL Impex Limited is audited by Alka Zanwar& Co. for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Alka Zanwar& Co. | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors and KMP of DRL Impex Limited
DRL Impex Limited currently reports 3 directors and 1 key managerial person. 13 former directors have served the organization.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mannam Venkata Narasimham Also directs: Dr.Reddy's Laboratories Ltd, Dr. Reddy's Formulations Limited, Cheminor Investments Ltd and 5 more | Director | 25 Sep 2014 | 12 Years 0 Months | Current |
| Namrata Also directs: University of Delhi Foundation | Director | 30 Oct 2019 | 6 Years 11 Months | Current |
| Narayana Reddy Vuyyuru | Ceo | 01 Feb 2017 | 9 Years 8 Months | Current |
| Vijay Kumar Hurgat Also directs: Cheminor Investments Ltd, Dr.Reddy's Research Foundation | Additional Director | 24 Nov 2025 | 0 Years 10 Months | Current |
Ownership and Shareholding of DRL Impex Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of DRL Impex Limited
DRL Impex Limited does not have any charges (loans) registered with the Registrar of Companies.
Deals & Funding of DRL Impex Limited
DRL Impex Limited has 5 deals on record (4 secondary share transfers, 1 acquisition); the latest was in July 2018.
Deals on record (5 of 5)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jul 2018 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Jul 2017 | Acquisition | Undisclosed | Buyer: Idea2enterprises (India) Private Limited Seller: Dr.Reddy's Laboratories Ltd |
| Jul 2015 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 2 individuals |
| Jul 2013 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: an individual |
| Sep 2006 | Secondary share transfer | Undisclosed | Buyer: Dr.Reddy's Laboratories Ltd Seller: 2 individuals |
Full deal history
All 5 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Employees and EPFO Compliance at DRL Impex Limited
Employment history and EPFO contributions of people linked to DRL Impex.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Name History of DRL Impex Limited
DRL Impex has undergone 3 name changes throughout its history. The company was previously known as Drl Investments Limited, Drl Finance Ltd, and Drl Pharmaceuticals Ltd. The current legal name is Drl Impex Limited.
| Company Name | Status |
|---|---|
| DRL Impex Limited | Current |
| Drl Investments Limited | Previous |
| Drl Finance Ltd | Previous |
| Drl Pharmaceuticals Ltd | Previous |
CIN History of DRL Impex Limited
DRL Impex has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U65990TG1986PLC006695, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U65990TG1986PLC006695 | Current |
| U99999AP1986PLC006695 | Previous |
| U65990AP1986PLC006695 | Previous |
Recent Activity on DRL Impex Limited
DRL Impex Limited has 24 board changes on record since 1987: 14 appointments and 10 cessations. The latest: Amit Parekh ceased to be Director on 24 Nov 2025.
15 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for DRL Impex Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by DRL Impex Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of DRL Impex Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of DRL Impex Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of DRL Impex Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about DRL Impex Limited
DRL Impex is an active public limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 18 August 1986 (40+ years old) and is registered under CIN U65990TG1986PLC006695.
DRL Impex reported revenue of ₹39.29 Lakh for FY 2025.
DRL Impex has 4 current directors and KMP:
- Mannam Venkata Narasimham - Director
- Namrata - Director
- Vijay Kumar Hurgat - Additional Director
- Narayana Reddy Vuyyuru - Ceo
DRL Impex reported a net loss of ₹15.06 Lakh (net margin -38.3%) and EBITDA of ₹38.69 Lakh (EBITDA margin 98.5%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of DRL Impex is 159% over five years. CAGR is the steady yearly rate that links the first and the last year.
The CIN (Corporate Identification Number) of DRL Impex is U65990TG1986PLC006695. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
DRL Impex was incorporated on 18 August 1986, making it 40+ years old. It is registered with the Registrar of Companies, Hyderabad.
DRL Impex has 5 deals on record (4 secondary share transfers, 1 acquisition); the latest was in July 2018.
The peers of DRL Impex by revenue are Marathwada Chemical Industries Private Limited, MKM Formulations Private Limited, Asap Pharmaceuticals Private Limited, VMP Health Care India Private Limited, Dr. Alson Laboratories Private Limited and 5 more, all in the Chemicals industry (Formulations, Industrial Chemicals).
Amit Parekh ceased to be Director on 24 Nov 2025. Vijay Kumar Hurgat was appointed as Additional Director on 24 Nov 2025. Amit Parekh was appointed as Director on 31 Jan 2023. DRL Impex has 24 board changes on record in total.
The registered office of DRL Impex is at 8 – 2 – 337 Road No. 3 Banjara Hills, Hyderabad, Telangana, India – 500034.